Company Filing History:
Years Active: 1999
Title: Innovations of James Guy Breitenbucher
Introduction
James Guy Breitenbucher is an accomplished inventor based in Richmond, California. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target neuropeptide Y (NPY) receptors. His work focuses on creating effective treatments for weight loss and eating disorders.
Latest Patents
Breitenbucher holds a patent for "Dihydropyridine NPY antagonists: cyanoguanidine derivatives." This patent describes a series of non-peptidergic antagonists of NPY, synthesized from cyanoguanidine derivatives of 4-phenyl-1,4-dihydropyridines. These compounds are designed to act as effective anorexiant agents, promoting weight loss and treating eating disorders by antagonizing NPY-induced feeding behavior.
Career Highlights
Breitenbucher is associated with Bristol-Myers Squibb Company, where he has contributed to various research initiatives. His innovative approach to drug development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Breitenbucher has collaborated with notable colleagues, including Graham S. Poindexter and R. Thomas Swann. These partnerships have enhanced the research and development of new therapeutic agents.
Conclusion
James Guy Breitenbucher exemplifies the spirit of innovation in the pharmaceutical field. His work on NPY antagonists showcases the potential for new treatments in weight management and eating disorders.